Look for:

Our offer for

NOVO-NORDISK AS B


ISIN:
DK0060534915
WKN:
-

2022/12/01 16:59:34
Price
892.60 DKK
Difference 0.97% (8.60)

General attributes

ISINDK0060534915
SymbolNOVO B
ExchangeNasdaq Copenhagen
CurrencyDKK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)204,524 EUR
BenchmarkOMX COPENHAGEN 20

Market data

Bid (Bid size)891.90 DKK (540)
Ask (Ask size)892.20 DKK (91)
Open885.30 DKK
High896.80 DKK
Low884.20 DKK
Close (prev. day)884.00 DKK
VWAP891.48769 DKK
Volume (pcs)1,342,966
Trading volume1,197,216,854.90
Number of trades14,273
Last size400

Futures and Options

Related Futures12
Related Options-

PDF Downloads

Company report: NOVO-NORDISK AS BPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2022/12/01 16:59:34
Price
892.60 DKK
Difference 0.97% (8.60)

General attributes

ISINDK0060534915
SymbolNOVO B
ExchangeNasdaq Copenhagen
CurrencyDKK
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)204,524 EUR
BenchmarkOMX COPENHAGEN 20

Market data

Bid (Bid size)891.90 DKK (540)
Ask (Ask size)892.20 DKK (91)
Open885.30 DKK
High896.80 DKK
Low884.20 DKK
Close (prev. day)884.00 DKK
VWAP891.48769 DKK
Volume (pcs)1,342,966
Trading volume1,197,216,854.90
Number of trades14,273
Last size400

Performance and Risk

6m1Y3Y
Perf (%)+16.01%+25.35%+134.16%
Perf (abs.)+123.20+180.50+511.40
Beta1.091.161.08
Volatility29.5234.0827.80
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)872.78 DKK (2,100,135)
Ø price 30 days | Ø volume 30 days (pcs.)831.15 DKK (1,804,389)
Ø price 100 days | Ø volume 100 days (pcs.)803.76 DKK (1,708,584)
Ø price 250 days | Ø volume 250 days (pcs.)760.09 DKK (1,915,489)
YTD High | date896.80 DKK (2022/12/01)
YTD Low | date604.40 DKK (2022/01/24)
52 Weeks High | date896.80 DKK (2022/12/01)
52 Weeks Low | date604.40 DKK (2022/01/24)

All listings for NOVO-NORDISK AS B

Exchange  DateTimePriceTrading volume (mio.)Number of trades
Xetra2022/12/0117:35119.74 EUR1.07202
Vienna Stock Exchange2022/12/0117:32120.40 EUR0.003
Tradegate2022/12/0118:57120.00 EUR3.20314
Stuttgart2022/12/0118:54120.06 EUR0.1915
SIX Swiss Exchange2022/04/2717:35108.58 CHF0.001
Nasdaq Copenhagen2022/12/0116:59892.60 DKK1,197.2214,273
Munich2022/12/0108:04119.42 EUR0.001
London Stock Exchange European Trade Reporting2022/12/0117:36892.60 DKK2.2421
Hanover2022/12/0108:18119.46 EUR0.001
Hamburg2022/12/0114:20120.26 EUR0.022
Frankfurt2022/12/0118:54119.54 EUR0.6324
FINRA other OTC Issues2022/12/0118:41123.30 USD1.2421
Duesseldorf2022/12/0118:30119.94 EUR0.0011
Berlin2022/12/0108:04119.38 EUR0.001

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=31640&ID_TYPE_IMAGE_LOGO=2

Contact Details

NOVO NORDISK A/S
- -
Novo Allé 1 - 2880 Bagsværd
Telefon: 45-44-44-88-88
Fax: -
E-mail: -

PDF Downloads

Company report: NOVO-NORDISK AS BPDF Download

Company Profile

Novo Nordisk A/S is a global healthcare company, which engages in the the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Biopharm segments. The Diabetes and Obesity Care segment includes insulin, GLP-1 and related delivery systems, oral antidiabetic products (OAD), obesity, and other serious chronic diseases. The Biopharm segment focuses on rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1925 is headquartered in Bagsværd, Denmark.

Members of Management Board

Lars Fruergaard JørgensenChairman of Managing Board
Camilla SylvestMember of Executive Committee
Doug LangaMember of Executive Committee
Henrik WulffMember of Executive Committee
Karsten Munk KnudsenMember of Executive Committee
Ludovic HelfgottMember of Executive Committee
Marcus SchindlerMember of Executive Committee
Martin Horst LangeMember of Executive Committee
Maziar Mike DoustdarMember of Executive Committee
Monique CarterMember of Executive Committee

Board of directors

Helge LundChairman of Supervisory Board
Martin MacKayMember of Supervisory Board
Sylvie GrégoireMember of Supervisory Board
Andreas FibigMember of Supervisory Board
Elisabeth ChristensenMember of Supervisory Board
Henrik PoulsenMember of Supervisory Board
Jeppe Fonager ChristiansenMember of Supervisory Board
Kasim KutayMember of Supervisory Board
Laurence DebrouxMember of Supervisory Board
Liselotte HyveledMember of Supervisory Board
Mette Bøjer JensenMember of Supervisory Board
Thomas RantzauMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer